Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action
John R. Ussher, Daniel J. Drucker
Topics & Concepts
MedicineHeart failureInternal medicineType 2 diabetesEndocrinologyDiabetes mellitusPostprandialBlood pressureGlucagon-like peptide-1Glucagon-like peptide 1 receptorReceptorPharmacologyAgonistDiabetes Treatment and ManagementPancreatic function and diabetesNeuropeptides and Animal Physiology